A newly funded Tropical Medicine Research Center at The Ohio State University will study factors that drive transmission and spread of visceral leishmaniasis, a serious parasitic disease in Eastern Africa that is fatal without ...
Sep 7, 2022
0
6
The drug artemisinin is the world's most important first-line drug for the treatment of malaria, a disease spread by mosquitoes that was responsible for 627,000 deaths globally in 2020. To prevent the malaria parasite (Plasmodium ...
Aug 29, 2022
1
48
Findings from a preliminary human study of an experimental, genetically attenuated malaria parasite immunization show this vaccine warrants further exploration.
Aug 24, 2022
0
36
One thing you might want even less than a "kiss" from a kissing bug is its feces. Scientifically referred to as triatomine bugs, these blood-sucking insects can carry in their feces and pass on to humans the parasite Trypanosoma ...
Aug 16, 2022
0
9
A study of how injured mouse cells trigger immune responses suggests novel strategies for preventing and treating everything from parasites to allergies in humans.
Aug 4, 2022
0
66
When Brazilian immunologist Helder Nakaya visited Evandro Chagas Institute in Belém (the capital of Pará state, Brazil) in 2017, there was a commotion because one of its best microscopists was retiring and much of the knowledge ...
Jul 28, 2022
0
8
Targeting a parasite's DNA could be a more effective way to combat malaria, new research from the University of Sheffield has revealed.
Jul 25, 2022
0
17
Advances in biology and medicinal chemistry, in conjunction with rising investment in research, have led to the development of promising new candidate treatments for some of the main neglected tropical diseases (NTDs) in ...
Jul 5, 2022
0
4
Findings from a new University of Kentucky College of Medicine study published in the Journal of Biological Chemistry May 28 may lead to a new treatment against Toxoplasma gondii, the parasite that causes toxoplasmosis.
Jul 1, 2022
0
1174
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no differences in relief of mild-to-moderate COVID-19 symptoms between participants taking ivermectin and participants ...
Jun 13, 2022
0
23
